COMPANY PROFILE · UPDATED 18 NOV 2025
Retension Pharmaceuticals
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical…
This profile is unclaimed — do you work here? Claim it
Claim it →- Founded
- 2023
- Headcount
- 2
- Open roles
- 0
- Last raised
- Series B · Sign in to view
LEADERSHIP
Founders & key people
OPEN ROLES
Hiring at Retension Pharmaceuticals
No open roles listed right now. Check back soon or search all jobs →
FUNDING
Capital raised
TAGS
Categorized in
LOCATIONS
Where they work
Retension Pharmaceuticals Headquarters Location
1104 West Broad Street #1029, Falls Church, VA, 22046
Loading map…